Interpretable Machine Learning Facilitates Disease Prognosis: Applications on COVID-19 and Onward

Haotian Chen; Ke Ma; Jinzhi Shen

doi:10.62051/ijcsit.v3n3.46

Authors

Haotian Chen
Ke Ma
Jinzhi Shen

DOI:

https://doi.org/10.62051/ijcsit.v3n3.46

Keywords:

Interpretable machine learning, Domain knowledge, Respiratory diseases, COVID-19, Prognosis

Abstract

In response to the COVID-19 pandemic, the integration of interpretable machine learning techniques has garnered significant attention, offering transparent and understandable insights crucial for informed clinical decision-making. This literature review delves into the applications of interpretable machine learning in predicting the prognosis of respiratory diseases, particularly focusing on COVID-19 and its implications for future research and clinical practice. We reviewed various machine learning models that are not only capable of incorporating existing clinical domain knowledge but also have the learning capability to explore new information from the data. These models and experiences not only aid in managing the current crisis but also hold promise for addressing future disease outbreaks. By harnessing interpretable machine learning, healthcare systems can enhance their preparedness and response capabilities, thereby improving patient outcomes and mitigating the impact of respiratory diseases in the years to come.

Downloads

Download data is not yet available.

References

[1] L. Yan et al., “An interpretable mortality prediction model for COVID-19 patients,” Nat. Mach. Intell., 2020, doi: 10.1038/s42256-020-0180-7.

[2] M. A. Ahmad, A. Teredesai, and C. Eckert, “Interpretable machine learning in healthcare,” in Proceedings - 2018 IEEE International Conference on Healthcare Informatics, ICHI 2018, 2018, doi: 10.1109/ICHI.2018.00095.

[3] H. Wu et al., “Interpretable Machine Learning for COVID-19: An Empirical Study on Severity Prediction Task,” IEEE Trans. Artif. Intell., vol. 4, no. 4, 2023, doi: 10.1109/TAI.2021.3092698.

[4] K. Rasheed, A. Qayyum, M. Ghaly, A. Al-Fuqaha, A. Razi, and J. Qadir, “Explainable, trustworthy, and ethical machine learning for healthcare: A survey,” Computers in Biology and Medicine, vol. 149. 2022, doi: 10.1016/j.compbiomed.2022.106043.

[5] G. Stiglic, P. Kocbek, N. Fijacko, M. Zitnik, K. Verbert, and L. Cilar, “Interpretability of machine learning-based prediction models in healthcare,” Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2020, doi: 10.1002/widm.1379.

[6] C. T. Kor, Y. R. Li, P. R. Lin, S. H. Lin, B. Y. Wang, and C. H. Lin, “Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease,” J. Pers. Med., vol. 12, no. 2, 2022, doi: 10.3390/jpm12020228.

[7] A. Bastug et al., “Clinical and laboratory features of COVID-19: Predictors of severe prognosis,” Int. Immunopharmacol., vol. 88, 2020, doi: 10.1016/j.intimp.2020.106950.

[8] E. Sepulchre et al., “Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution,” Acta Clin. Belgica Int. J. Clin. Lab. Med., vol. 77, no. 2, 2022, doi: 10.1080/17843286.2020.1822078.

[9] G. C. Pinasco et al., “An interpretable machine learning model for COVID-19 screening,” J. Hum. Growth Dev., vol. 32, no. 2, 2022, doi: 10.36311/jhgd.v32.13324.

[10] Y. Fan, M. Liu, and G. Sun, “An interpretable machine learning framework for diagnosis and prognosis of COVID-19,” PLoS One, vol. 18, no. 9 September, 2023, doi: 10.1371/journal.pone.0291961.

[11] H. Huang et al., “Prognostic factors for COVID-19 pneumonia progression to severe symptom based on the earlier clinical features: a retrospective analysis,” medRxiv, p. 2020.03.28.20045989, Jan. 2020, doi: 10.1101/2020.03.28.20045989.

[12] J. Lee, J. H. Kim, C. Ta, C. Liu, and C. Weng, “Severity prediction for COVID-19 patients via recurrent neural networks,” medRxiv. 2020, doi: 10.1101/2020.08.28.20184200.

[13] M. A. Callejon-Leblic et al., “Loss of Smell and Taste Can Accurately Predict COVID-19 Infection: A Machine-Learning Approach,” J. Clin. Med., vol. 10, no. 4, 2021, doi: 10.3390/jcm10040570.

[14] X. Li et al., “Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis,” Crit. Care, vol. 24, no. 1, pp. 1–10, 2020.

[15] X. Ma et al., “Development and validation of prognosis model of mortality risk in patients with COVID-19,” Epidemiol. Infect., vol. 148, p. e168, 2020, doi: https://doi.org/10.1017/S0950268820001727.

[16] M. Hendryx and J. Luo, “COVID-19 Prevalence and Mortality Rates in Association with Black Race and Segregation in the United States April 1 to April 15, 2020,” SSRN Electron. J., 2020, doi: 10.2139/ssrn.3582857.

[17] Y. Shang et al., “Scoring Systems for Predicting Mortality for Severe Patients with COVID-19,” SSRN Electron. J., vol. 000, no. December 2019, p. 100426, 2020, doi: 10.2139/ssrn.3582752.

[18] M. Jha, R. Gupta, and R. Saxena, “A Precise Method to Detect Post-COVID-19 Pulmonary Fibrosis Through Extreme Gradient Boosting,” SN Comput. Sci., vol. 4, no. 1, p. 89, 2022, doi: https://doi.org/10.1007/s42979-022-01526-x.

[19] M. Bilal, M. I. Khan, M. S. Nazir, I. Ahmed, and H. M. N. Iqbal, “Coronaviruses and COVID-19 – Complications and lessons learned for the future,” Journal of Pure and Applied Microbiology, vol. 14, no. 1. 2020, doi: 10.22207/JPAM.14.SPL1.09.

[20] C. R. Triggle, D. Bansal, E. A. B. A. Farag, H. Ding, and A. A. Sultan, “COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions,” mSphere, vol. 5, no. 3, 2020, doi: 10.1128/msphere.00317-20.